Explore /
Poster
/ A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).

Authors

Phuoc T. Tran

Johns Hopkins School of Medicine, Baltimore, MD

Phuoc T. Tran , Ryan Phillips , William Shi , Su Jin Lim , Emmanuel S. Antonarakis , Steven P. Rowe , Ashley Ross , Michael A. Gorin , Curtiland Deville , Stephen C. Greco , Channing Judith Paller , Theodore L. DeWeese , Daniel Y. Song , Hao Wang , Michael Anthony Carducci , Kenneth J. Pienta , Martin Pomper , Adam P. Dicker , Mario A. Eisenberger , Maximilian Diehn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT02680587

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 116)

Abstract #

116

Poster Bd #

E18

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Genitourinary Cancers Symposium

NRG-GU011: A phase II double-blinded, placebo-controlled trial of prostate oligometastatic radiotherapy with or without androgen deprivation therapy in oligometastatic prostate cancer (NRG PROMETHEAN).

First Author: Bridget F. Koontz

Poster

2020 Genitourinary Cancers Symposium

A phase II, open-label study of durvalumab in combination with stereotactic body radiotherapy in androgen-intact patients with oligometastatic prostate cancer.

First Author: Isobel Porter

Poster

2017 ASCO Annual Meeting